#ANIX Anixa Biosciences Announces First Case of Stable Disease for Three Months in Ovarian Cancer CAR-T Clinical Trial

#ANIX Anixa Biosciences Announces First Case of Stable Disease for Three Months in Ovarian Cancer CAR-T Clinical Trial
#ANIX Anixa Biosciences Announces Treatment of Second Patient in the Fifth Cohort of its Ovarian Cancer CAR-T Clinical Trial
π Today's Insider Activity β 4 filings
$ANIX β Catelani Michael, President, COO, & CFO (BUY, $16K)
$KWY β Fitzgerald John Taylor Maloney, President and CEO (BUY, $3K)
$KWY β Hansen Kent A, CFO & EVP (BUY, $2K)
$SFBC β Stewart Laura Lee, Chief Executive Officer (SELL, $41K)
π Search any ticker β
π’ $ANIX β Titterton Lewis H jr, Director
BOUGHT: 49,036 shares @ $2.69
Total: $132K
Filed Sep 22, 2026 Β· 8:00pm ET
π History & trend β https://www.formdelta.com/ticker/ANIX
π $ANIX 10-Q β what changed
MD&A now says: "RESULTS OF OPERATIONS Three months ended July 31, 2026 compared with three months ended July 31, 2025 Revenue We had no revenue during the three-month periods ended July 31, 2026 and 2025."
π Full redline β https://www.formdelta.com/ticker/ANIX
#ANIX Anixa Biosciences Granted First Australian Patent for its Breast Cancer Vaccine, Broadening Global Protection Through 2040
I looked at the business behind $ANIX (Anixa Biosciences Inc) for you. Based on financial data and reported results.
Read my simple explanation: https://penkeinvesti...
I looked at the business behind $ANIX (Anixa Biosciences Inc) for you. Based on financial data and reported results.
Read my simple explanation: https://penkeinvesti...
#ANIX Anixa Biosciences to Present at the Nasdaq & LD Micro Inaugural SF Summit on September 9, 2026